Paxman AB (PAX) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.014x

Based on the latest financial reports, Paxman AB (PAX) has a cash flow conversion efficiency ratio of -0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-5.98 Million ≈ $-643.87K USD) by net assets (Skr427.76 Million ≈ $46.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Paxman AB's balance sheet to measure how much of total assets are equity-financed.

Paxman AB - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Paxman AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check PAX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Paxman AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Paxman AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
vTv Therapeutics Inc NASDAQ:VTVT	0.102x
China Electric Manufacturing Corp TW:1611	0.009x
Servotronics Inc NYSE MKT:SVT	-0.067x
Organic Tea Cosmetics Holdings Company Limited KQ:900300	0.098x
Inseego Corp NASDAQ:INSG	-0.067x
CTW Cayman Class A Ordinary Shares NASDAQ:CTW	-0.089x
Torimbia Socimi S.A. MC:YTRM	0.191x
Acusensus Ltd AU:ACE	0.023x

Annual Cash Flow Conversion Efficiency for Paxman AB (2017–2024)

The table below shows the annual cash flow conversion efficiency of Paxman AB from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see PAX market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr163.99 Million ≈ $17.65 Million	Skr39.10 Million ≈ $4.21 Million	0.238x	+87.04%
2023-12-31	Skr122.62 Million ≈ $13.20 Million	Skr15.63 Million ≈ $1.68 Million	0.127x	+442.03%
2022-12-31	Skr114.20 Million ≈ $12.29 Million	Skr2.69 Million ≈ $289.06K	0.024x	+171.39%
2021-12-31	Skr125.75 Million ≈ $13.53 Million	Skr-4.14 Million ≈ $-445.85K	-0.033x	+95.77%
2020-12-31	Skr10.89 Million ≈ $1.17 Million	Skr-8.48 Million ≈ $-913.01K	-0.779x	-768.59%
2019-12-31	Skr28.36 Million ≈ $3.05 Million	Skr3.31 Million ≈ $355.67K	0.117x	+639.81%
2018-12-31	Skr25.39 Million ≈ $2.73 Million	Skr400.00K ≈ $43.05K	0.016x	+107.24%
2017-12-31	Skr32.77 Million ≈ $3.53 Million	Skr-7.13 Million ≈ $-767.62K	-0.218x	--

About Paxman AB

ST:PAX Sweden Medical Devices

Market Cap

$119.97 Million

Skr1.11 Billion SEK

Market Cap Rank

#18447 Global

#320 in Sweden

Share Price

Skr47.90

Change (1 day)

-0.10%

52-Week Range

Skr44.00 - Skr79.40

All Time High

Skr83.80